Industry expert argues that President Donald Trump's omission of Bitcoin and crypto in Tuesday's congressional address puts his policy position in doubt. Over the past year, President Donald Trump has ...

Calumet Specialty Products Partners (NASDAQ:CLMT – Get Free Report) was downgraded by research analysts at TD Cowen from a ...

Research analysts at TD Cowen started coverage on shares of Sionna Therapeutics (NASDAQ:SION – Get Free Report) in a research report issued to clients and investors on Tuesday, Marketbeat.com reports.

Investment bank TD Cowen noted that President Donald Trump did not mention cryptocurrency in his Congress speech.

Economic forecasts have been weakening. While some see slower growth, several commentators see the chance of an outright ...

Moderna, Inc. ( NASDAQ: MRNA) TD Cowen 45th Annual Health Care Conference March 5, 2025 9:10 AM ET All right, well, good morning, everyone. Tyler Van Buren here, Senior Biotech Analyst at TD Cowen.

TD Cowen analyst John Kernan lowered the firm’s price target on On Holding (ONON) to $64 from $66 and keeps a Buy rating on the shares. The ...

Calumet downgraded at TD Cowen, saying the market has more fully accounted for near-term risks both for the Montana Renewable ...

The newly listed clinical-stage biotechnology company, Metsera Inc. rose 15.01% on Monday as the broader markets declined.

Merck’s stock has fallen 7.27% year-to-date, raising investor concerns. Despite a 1.84% gain on Friday, the stock remains ...

We recently compiled a list of the 11 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...

As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert ...